Eli Lilly Stock (LLY) Is Up, What You Need To Know
Shares of global pharmaceutical company Eli Lilly (NYSE: LLY ) jumped 3.4% in the morning session after the company announced very positive results of the Phase 3 trial for its next-generation weight loss candidate, retatrutide. The triple agonist drug, which activates three hormone receptors (GIP, GLP-1, and glucagon), met all key primary and secondary endpoints … Read more